Immunization Update: 2024 Vaccine Schedules for Infants, Children, and Adolescents
After sharp declines during the COVID-19 pandemic, vaccination rates among children are rising but vaccine hesitancy continues among many parents.
After sharp declines during the COVID-19 pandemic, vaccination rates among children are rising but vaccine hesitancy continues among many parents.
Abyrsvo is the first vaccine approved for pregnant individuals to prevent RSV disease in infants.
Despite the availability of a highly effective shingles vaccine and almost universal risk among those born before 1980, Americans are not getting vaccinated.
There are currently no vaccines approved for preventing Neisseria gonorrhoeae infection.
Several changes have been made to the adult immunization schedule 2023.
M-M-R II, Varivax, and ProQuad are supplied in single-dose vials as lyophilized vaccine for SC or IM injection after reconstitution.
The BLA is supported by data from a phase 3 trial which included approximately 7400 pregnant individuals.
The decision to discontinue the study was made based on an analysis from an independent data and safety monitoring board.
The approval was based on a re-analysis of data from on observational study of Tdap vaccine effectiveness in the US.
The combined vaccine is intended to simplify immunization practices against 2 severe respiratory diseases caused by evolving viruses that require vaccine adaptation.